Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank78
3Y CAGR+45.9%
5Y CAGR+1.8%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+45.9%/yr
vs -7.7%/yr prior
5Y CAGR
+1.8%/yr
Recent acceleration
Acceleration
+53.6pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$101.54M-61.6%
2024$264.55M+381.9%
2023$54.90M+68.0%
2022$32.67M-83.7%
2021$200.69M+115.6%
2020$93.09M+130.8%
2019$40.33M-10.3%
2018$44.97M+216.9%
2017$14.19M+16.8%
2016$12.15M-